(Editor's note: With stocks hovering at new lows for 2016 Thursday, we asked Chris Kimble, founder and CEO of Kimble Charting Solutions for his technical analysis of the market.)
Jim Cramer spoke with JJ Bienaimé for more on the company's newest drug that treats a very rare disease.
Jim Cramer looks ahead to a tidal wave of earnings and seeks out buying opportunities.
Infrastructure stocks got a big boost after Trump's election, but the run is "not even beginning," Mario Gabelli says.
Wall Street has raised its expectations for Amazon and Google's parent company, Alphabet.